The studies were carried out in collaboration with Siena Biotech and involve the identification of novel small molecules with potential of modulating diseases. On the basis of well known patented compounds we focused our attention on the synthesis of : 4-aminopiperidine derivatives, tetraline derivatives and carbazole derivatives
Alzheimer’s disease (AD) is the most common cause of dementia among older people, and the prevalence...
Pathological, genetic, biochemical and pharmacological studies support the hypothesis that brain acc...
Magister Scientiae - MScAlzheimer's disease (AD) is an age related neurodegenerative disorder charac...
β-Secretase is the enzyme responsible for the Amyloid-β plaques found in Alzheimer’s disease. Inhibi...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, presenting itself clinical...
The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential ...
Nowadays identification of novel non-peptide β-secretase (BACE-1, hereinafter) inhibitors with low c...
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD) have tran...
Alzheimer's disease (AD) is the most common form of dementia in the elderly with progressive cogniti...
Alzheimer’s disease is the most prevailing type of dementia worldwide with pathological hallmarks as...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
Alzheimer’s disease (AD) is a complex and progressive neurodegenerative disorder. The available the...
Effective treatment of Alzheimer's disease (AD) remains a critical unmet need in medicine. The lack ...
Alzheimer’s disease (AD) is the most common cause of dementia among older people, and the prevalence...
Pathological, genetic, biochemical and pharmacological studies support the hypothesis that brain acc...
Magister Scientiae - MScAlzheimer's disease (AD) is an age related neurodegenerative disorder charac...
β-Secretase is the enzyme responsible for the Amyloid-β plaques found in Alzheimer’s disease. Inhibi...
Alzheimer's disease (AD) is the leading cause of dementia in the elderly, presenting itself clinical...
The amyloid hypothesis has yielded a series of well-validated candidate drug targets with potential ...
Nowadays identification of novel non-peptide β-secretase (BACE-1, hereinafter) inhibitors with low c...
In the last decade, advances in understanding the neurobiology of Alzheimer's disease (AD) have tran...
Alzheimer's disease (AD) is the most common form of dementia in the elderly with progressive cogniti...
Alzheimer’s disease is the most prevailing type of dementia worldwide with pathological hallmarks as...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits...
Alzheimer’s disease (AD) is a complex and progressive neurodegenerative disorder. The available the...
Effective treatment of Alzheimer's disease (AD) remains a critical unmet need in medicine. The lack ...
Alzheimer’s disease (AD) is the most common cause of dementia among older people, and the prevalence...
Pathological, genetic, biochemical and pharmacological studies support the hypothesis that brain acc...
Magister Scientiae - MScAlzheimer's disease (AD) is an age related neurodegenerative disorder charac...